From: Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
Variables | Overall survival rate (%) | Disease-free survival rate (%) | ||||
---|---|---|---|---|---|---|
 | 3 y | 5 y | P value | 3 y | 5 y | P value |
Gender | Â | Â | Â | Â | Â | Â |
   Female (n = 9) | 100.0 | 81.8 | 0.438 | 77.8 | 77.8 | 0.473 |
   Male (n = 58) | 75.7 | 71.1 |  | 62.3 | 62.3 |  |
Age (years) | Â | Â | Â | Â | Â | Â |
   ≤ 50 (n = 32) | 87.4 | 80.4 | 0.213 | 71.3 | 71.3 | 0.560 |
   > 50 (n = 35) | 73.0 | 65.7 |  | 59.4 | 59.4 |  |
HBsAg status | Â | Â | Â | Â | Â | Â |
   Negative (n = 13) | 83.9 | 83.9 | 0.752 | 76.2 | 76.2 | 0.426 |
   Positive (n = 54 | 78.2 | 69.4 |  | 62.1 | 62.1 |  |
AFP (μg/l) |  |  |  |  |  |  |
   ≤ 400 (n = 43) | 71.0 | 65.3 | 0.199 | 62.1 | 62.1 | 0.690 |
   > 400 (n = 24) | 91.1 | 82.8 |  | 68.0 | 68.0 |  |
Cirrhosis | Â | Â | Â | Â | Â | Â |
   No (n = 8) | 100.0 | 100.0 | 0.128 | 75.0 | 75.0 | 0.565 |
   Yes (n = 59) | 76.0 | 67.5 |  | 63.2 | 63.2 |  |
Child-Pugh classification | Â | Â | Â | Â | Â | |
   A (n = 61) | 78.9 | 75.5 | 0.499 | 67.2 | 67.2 | 0.519 |
   B (n = 6) | 83.3 | 55.6 |  | 44.4 | 44.4 |  |
Tumour size (cm) | Â | Â | Â | Â | Â | Â |
   ≤ 5 (n = 40) | 82.6 | 82.6 | 0.061 | 77.7 | 77.7 | 0.006 |
   > 5 (n = 27) | 73.0 | 57.0 |  | 45.7 | 45.7 |  |
Tumour capsule | Â | Â | Â | Â | Â | Â |
   Complete (n = 26) | 81.0 | 81.0 | 0.787 | 67.3 | 67.3 | 0.957 |
   No/incomplete (n = 41) | 79.1 | 68.3 |  | 63.3 | 63.3 |  |
Edmondson-Steiner grade | Â | Â | Â | Â | Â | |
   I/II (n = 46) | 80.9 | 80.9 | 0.172 | 68.3 | 68.3 | 0.338 |
   III/IV (n = 21) | 73.7 | 60.0 |  | 57.1 | 57.1 |  |
MACC1 expression level | Â | Â | Â | Â | Â | |
   Low (n = 37) | 85.6 | 85.6 | 0.021 | 76.5 | 76.5 | 0.017 |
   High (n = 30) | 71.1 | 53.3 |  | 49.4 | 49.4 |  |